UBS AM’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-18,448
| Closed | -$1.98M | – | 2744 |
|
|
2023
Q2 | $1.98M | Hold |
18,448
| – | – | ﹤0.01% | 1648 |
|
|
2023
Q1 | $1.98M | Sell |
18,448
-76
| -0.4% | -$8.16K | ﹤0.01% | 1648 |
|
|
2022
Q4 | $2.04M | Buy |
18,524
+12,324
| +199% | +$1.36M | ﹤0.01% | 1514 |
|
|
2022
Q3 | $366K | Buy |
+6,200
| New | +$366K | ﹤0.01% | 2448 |
|
|
2022
Q2 | – | Sell |
-6,200
| Closed | -$234K | – | 2811 |
|
|
2022
Q1 | $234K | Buy |
+6,200
| New | +$234K | ﹤0.01% | 2647 |
|